RespireRx

Published: Nov. 15, 2021, 5 p.m.

b'

RespireRx (OTCQB: RSPI) is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of psychiatric and neurological disorders. President and CEO Tim Jones joins us to discuss the company\\u2019s competitive advantage in the biotechnology space.

\\xa0

View Podcast Transcript for RespireRx

'